Toronto - Delayed Quote CAD
Aptose Biosciences Inc. (APS.TO)
2.3500
-0.1900
(-7.48%)
At close: May 14 at 3:58:14 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| RICE WILLIAM GLENN Chief Executive Officer | Purchase | Nov 25, 2024 | 613,252 |
| SEIZINGER BERND R. Director | Purchase | Sep 22, 2023 | 17,000 |
Related Tickers
BCT.TO BriaCell Therapeutics Corp.
4.2400
-4.72%
ACTU Actuate Therapeutics, Inc. Common stock
9.65
+0.10%
MDNA.TO Medicenna Therapeutics Corp.
1.0500
-4.55%
RNXT RenovoRx, Inc.
1.0500
+1.94%
RNTX Rein Therapeutics Inc.
2.2500
+14.80%
CUE Cue Biopharma, Inc.
0.7451
-2.97%
ONC.TO Oncolytics Biotech Inc.
0.7100
-1.39%
DSGN Design Therapeutics, Inc.
3.2150
-9.94%
LYEL Lyell Immunopharma, Inc.
0.3900
-3.61%
APLMW Apollomics, Inc.
0.0111
-26.00%